{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T10:36:38Z","timestamp":1771583798863,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10067-026-07944-z","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T12:19:44Z","timestamp":1768997984000},"page":"1677-1685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structural remission rate and factors associated with radiographic progression in patients with rheumatoid arthritis treated with sarilumab in clinical practice"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3161-3929","authenticated-orcid":false,"given":"Masahiro","family":"Tada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuaki","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Anno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Okano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"7944_CR1","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388:2023\u20132038. https:\/\/doi.org\/10.1016\/S0140-6736(16)30173-8","journal-title":"Lancet"},{"key":"7944_CR2","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1136\/ard.2011.154179","volume":"70","author":"B Haraoui","year":"2011","unstructured":"Haraoui B, Smolen JS, Aletaha D et al (2011) Treating Rheumatoid Arthritis to target: multinational recommendations assessment questionnaire. Ann Rheum Dis 70:1999\u20132002. https:\/\/doi.org\/10.1136\/ard.2011.154179","journal-title":"Ann Rheum Dis"},{"key":"7944_CR3","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.7150\/ijbs.4666","volume":"8","author":"T Tanaka","year":"2012","unstructured":"Tanaka T, Kishimoto T (2012) Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases. Int J Biol Sci 8:1227\u20131236. https:\/\/doi.org\/10.7150\/ijbs.4666","journal-title":"Int J Biol Sci"},{"key":"7944_CR4","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/art.39093","volume":"67","author":"MC Genovese","year":"2015","unstructured":"Genovese MC, Fleischmann R, Kivitz AJ et al (2015) Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a phase III study. Arthritis Rheumatol 67:1424\u20131437. https:\/\/doi.org\/10.1002\/art.39093","journal-title":"Arthritis Rheumatol"},{"key":"7944_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13075-020-02163-6","volume":"22","author":"C Gabay","year":"2020","unstructured":"Gabay C, Burmester GR, Strand V et al (2020) Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes. Arthritis Res Ther 22:70. https:\/\/doi.org\/10.1186\/s13075-020-02163-6","journal-title":"Arthritis Res Ther"},{"key":"7944_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000887","volume":"5","author":"MC Genovese","year":"2019","unstructured":"Genovese MC, van der Heijde D, Lin Y et al (2019) Long-term safety and efficacy of sarilumab plus methotrexate on disease activity, physical function and radiographic progression: 5 years of sarilumab plus methotrexate treatment. RMD Open 5:e000887. https:\/\/doi.org\/10.1136\/rmdopen-2018-000887","journal-title":"RMD Open"},{"key":"7944_CR7","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580\u20131588. https:\/\/doi.org\/10.1136\/ard.2010.138461","journal-title":"Ann Rheum Dis"},{"key":"7944_CR8","doi-asserted-by":"publisher","unstructured":"Prevoo ML, van \u2019t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44\u201348. https:\/\/doi.org\/10.1002\/art.1780380107","DOI":"10.1002\/art.1780380107"},{"key":"7944_CR9","first-page":"S100","volume":"23","author":"D Aletaha","year":"2005","unstructured":"Aletaha D, Smolen J (2005) The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 23:S100-108","journal-title":"Clin Exp Rheumatol"},{"key":"7944_CR10","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/art.1780261107","volume":"26","author":"T Pincus","year":"1983","unstructured":"Pincus T, Summey JA, Soraci SA Jr., Wallston KA, Hummon NP (1983) Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 26:1346\u20131353. https:\/\/doi.org\/10.1002\/art.1780261107","journal-title":"Arthritis Rheum"},{"key":"7944_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/jama.1949.02900430001001","volume":"140","author":"O Steinbrocker","year":"1949","unstructured":"Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc 140:659\u2013662. https:\/\/doi.org\/10.1001\/jama.1949.02900430001001","journal-title":"J Am Med Assoc"},{"key":"7944_CR12","first-page":"261","volume":"27","author":"D van der Heijde","year":"2000","unstructured":"van der Heijde D (2000) How to read radiographs according to the Sharp\/van der Heijde method. J Rheumatol 27:261\u2013263","journal-title":"J Rheumatol"},{"key":"7944_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrrheum.2011.202","volume":"8","author":"S Lillegraven","year":"2012","unstructured":"Lillegraven S, van der Heijde D, Uhlig T, Kvien TK, Haavardsholm EA (2012) What is the clinical relevance of erosions and joint space narrowing in RA? Nat Rev Rheumatol 8:117\u2013120. https:\/\/doi.org\/10.1038\/nrrheum.2011.202","journal-title":"Nat Rev Rheumatol"},{"key":"7944_CR14","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","volume":"8","author":"G Schett","year":"2012","unstructured":"Schett G, Gravallese E (2012) Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat Rev Rheumatol 8:656\u2013664. https:\/\/doi.org\/10.1038\/nrrheum.2012.153","journal-title":"Nat Rev Rheumatol"},{"key":"7944_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000798","volume":"5","author":"E Choy","year":"2019","unstructured":"Choy E, Freemantle N, Proudfoot C et al (2019) Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying antirheumatic drugs or tumour necrosis factor alpha inhibitors: systematic literature review and network meta-analyses. RMD Open 5:e000798. https:\/\/doi.org\/10.1136\/rmdopen-2018-000798","journal-title":"RMD Open"},{"key":"7944_CR16","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1136\/annrheumdis-2015-208426","volume":"75","author":"Y Kaneko","year":"2016","unstructured":"Kaneko Y, Atsumi T, Tanaka Y et al (2016) Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study). Ann Rheum Dis 75:1917\u20131923. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208426","journal-title":"Ann Rheum Dis"},{"key":"7944_CR17","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/acr.24524","volume":"74","author":"MMA Verhoeven","year":"2022","unstructured":"Verhoeven MMA, Tekstra J, Jacobs JWG et al (2022) Efficacy of tocilizumab monotherapy versus tocilizumab and methotrexate combination therapy in the prevention of radiographic progression in rheumatoid arthritis: an analysis using individual patient data from multiple clinical trials. Arthritis Care Res (Hoboken) 74:889\u2013895. https:\/\/doi.org\/10.1002\/acr.24524","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07944-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-07944-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07944-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T09:53:38Z","timestamp":1771581218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-07944-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["7944"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-07944-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committees of the Osaka Metropolitan University (IRB approval number: 2021\u2013096) and other hospitals approved the study protocol. Written, informed consent to participate in this study was obtained from all patients in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}